FOXM1 inhibitor, Siomycin A, synergizes and restores 5-FU cytotoxicity in human cholangiocarcinoma cell lines via targeting thymidylate synthase.

MLA

Klinhom-On, Nathakan, et al. “FOXM1 Inhibitor, Siomycin A, Synergizes and Restores 5-FU Cytotoxicity in Human Cholangiocarcinoma Cell Lines via Targeting Thymidylate Synthase.” Life Sciences, vol. 286, Dec. 2021, p. 120072. EBSCOhost, https://doi.org/10.1016/j.lfs.2021.120072.

APA

Klinhom-On, N., Seubwai, W., Sawanyawisuth, K., Obchoei, S., Mahalapbutr, P., & Wongkham, S. (2021). FOXM1 inhibitor, Siomycin A, synergizes and restores 5-FU cytotoxicity in human cholangiocarcinoma cell lines via targeting thymidylate synthase. Life Sciences, 286, 120072. https://doi.org/10.1016/j.lfs.2021.120072

Chicago

Klinhom-On, Nathakan, Wunchana Seubwai, Kanlayanee Sawanyawisuth, Sumalee Obchoei, Panupong Mahalapbutr, and Sopit Wongkham. 2021. “FOXM1 Inhibitor, Siomycin A, Synergizes and Restores 5-FU Cytotoxicity in Human Cholangiocarcinoma Cell Lines via Targeting Thymidylate Synthase.” Life Sciences 286 (December): 120072. doi:10.1016/j.lfs.2021.120072.